What Are Your Chances of Contracting Prostate Cancer?

Prostate cancer is considered the most common cancer affecting men. It's the second foremost cause of cancer deaths among males. Age counts amongst the major risk factors of the disease. Indeed, prostate cancer rises in frequency as men hit the 65 and above age mark. This illness is more rampant in Western countries, with around 10% of cases being related to family history. Recurrence rates for prostate cancer are fairly high.

For the most part, prostate cancer is a disease that progresses from localized to locally advanced to advanced to the hormone refractory stages. Prostate cancer is a type of cancer that is slow to grow. It is primarily under the hormonal control of testosterone. Treatment options include surgery or prostatectomy, hormonal therapy, vigilant waiting, radiotherapy and chemotherapy. The question of which treatment is best will largely depend on how far along the disease is.

Treating Prostate Cancer

Early detection via biopsies and other determination tests along with appropriate treatment usually yield excellent survival rates. Treating prostate cancer on an as needed basis remains the main focus of the various treatment choices. Decisions regarding how best to manage the prostate cancer are dependent on a few things - the impact of a particular treatment on quality of living, age and health condition of patients upon diagnosis, prostate cancer pathology, the patient's treatment preference and stage of the cancer.

Prostate cancer can be treated any number of ways. Some undergo surgery while others get hormonal endocrine therapy. Other options for treatment include radiotherapy and/or brachytherapy, chemotherapy and investigational therapy.

Prostate Cancer Comeback Rates

Thanks to increased awareness and better screening techniques, detection of prostate cancer during its earlier stages is now possible. However, despite the availability of definitive therapies, some prostate cancer cells can remain, going unnoticed for years till they change into a metastatic disease.

The danger of prostate cancer recurring is particularly high. There is definitely a need to enhance current prostate cancer treatment approaches. Predicting the pathological stage of prostate cancer as well as the recurrence risk levels early on will definitely enable the most appropriate treatment to be done. Hopefully, ongoing research and development in these fields will bring us closer to realizing reduced prostate cancer recurrence rates.